The p27 Kip1 gene is an inductor of cell-cycle arrest at the G1 checkpoint, preventing entry of somatic cells into the S phase of the cell cycle when substantial DNA damage has occurred. It has been suggested that decreased expression of the p27 Kip1 protein may contribute to the development of human malignancies due to the loss of critical antiproliferative mechanisms.
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Method
This study investigated 95 specimens (T1±T4) from 95 randomly selected patients who underwent radical prostatectomy at the urological department at Hanover University (82 patients) and the Josef Hospital, Regensburg (13 patients) between 1981 and 1992 and for whom tissue blocks for immunohistochemical investigation were available. The specimens were investigated for different biological and clinical characteristics as possible predictors of recurrence-free and long-term survival: age, depth of tumour in®ltration, histological grade, lymph node status and decreased expression of the p27 Kip1 protein.
Results
After a median follow-up of 56 months (24±151 months), seven out of 21 (33%) patients who had loss of p27 Kip1 protein expression or a relative amount of`10% of positively stained tumour cells (Group 1) developed recurrent disease, as opposed to 17 out of 74 (23%) patients who retained p27 Kip1 protein expression ( 3 10% of positively stained tumour cells, Group 2). The median recurrence-free survival was 14 months (5±40 months) for patients in Group 1 and 31 months (7±133 months) for patients in Group 2 (P 0.02). In multivariate analysis, loss of p27 Kip1 protein expression was identi®ed as the only independent prognostic parameter for recurrence-free survival. In contrast, neither the univariate nor the multivariate analysis showed a correlation between loss of p27 Kip1 protein expression and the patients' long-term survival.
Conclusion
Prospective studies are urgently needed to con®rm the independent prognostic value of decreased p27 Kip1 protein expression, together with overexpression of the p53 tumour suppressor protein in patients with localized prostate cancer.
The availability of more re®ned, prognostically important biological variables in addition to established prognostic factors such as tumour stage or Gleason score might assist decision-making for patients at high risk of developing local recurrence of systemic tumour progression.
